Senti Biosciences, Inc. (SNTI) DCF Valuation

Senti Biosciences, Inc. (SNTI) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Senti Biosciences, Inc. (SNTI) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Senti Biosciences, Inc.'s financial outlook like an expert! This (SNTI) DCF Calculator provides pre-filled financial data along with the freedom to modify revenue growth, WACC, profit margins, and other crucial assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .1 .4 2.3 4.3 2.6 4.1 6.7 10.8 17.5 28.3
Revenue Growth, % 0 363.53 481.47 87.08 -40.25 61.71 61.71 61.71 61.71 61.71
EBITDA -21.4 -22.7 -39.7 -70.6 -61.3 -4.1 -6.7 -10.8 -17.5 -28.3
EBITDA, % -25123.53 -5763.71 -1731.86 -1647.9 -2395 -100 -100 -100 -100 -100
Depreciation .4 2.0 3.0 3.9 5.4 4.1 6.6 10.6 17.2 27.8
Depreciation, % 502.35 503.81 131.38 90.74 211.99 98.15 98.15 98.15 98.15 98.15
EBIT -21.8 -24.7 -42.7 -74.5 -66.8 -4.1 -6.7 -10.8 -17.5 -28.3
EBIT, % -25625.88 -6267.51 -1863.25 -1738.64 -2606.99 -100 -100 -100 -100 -100
Total Cash 17.8 30.5 56.0 98.6 35.9 4.1 6.7 10.8 17.5 28.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .1 .3 .5 .6 17.7
Account Receivables, % 91.76 80.46 21.08 14.61 691.29
Inventories .0 .0 2.6 3.3 .0 1.5 2.5 4.0 6.4 10.4
Inventories, % 0 6.35 113.62 76.74 0 36.62 36.62 36.62 36.62 36.62
Accounts Payable 1.2 .9 5.2 1.4 1.3 3.2 5.1 8.2 13.3 21.6
Accounts Payable, % 1408.24 231.98 226.41 31.96 48.81 76.15 76.15 76.15 76.15 76.15
Capital Expenditure -2.0 -1.2 -5.5 -41.4 -12.0 -4.1 -6.7 -10.8 -17.5 -28.3
Capital Expenditure, % -2348.24 -294.67 -241.95 -965.33 -470.05 -100 -100 -100 -100 -100
Tax Rate, % -11.41 -11.41 -11.41 -11.41 -11.41 -11.41 -11.41 -11.41 -11.41 -11.41
EBITAT -21.8 -24.7 -42.7 -74.5 -74.4 -4.1 -6.7 -10.8 -17.5 -28.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -22.2 -24.4 -43.7 -116.6 -94.9 11.3 -7.4 -11.9 -19.3 -31.2
WACC, % 8.54 8.54 8.54 8.54 8.54 8.54 8.54 8.54 8.54 8.54
PV UFCF
SUM PV UFCF -39.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -32
Terminal Value -487
Present Terminal Value -323
Enterprise Value -363
Net Debt 2
Equity Value -365
Diluted Shares Outstanding, MM 4
Equity Value Per Share -82.15

What You Will Get

  • Comprehensive Financial Model: Senti Biosciences’ actual data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential metrics.
  • Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Customizable Growth Projections: Adjust essential parameters such as revenue growth, gross margin %, and R&D expenditures.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional financial metrics.
  • High-Precision Analytics: Leverages Senti Biosciences’ actual financial data for accurate valuation assessments.
  • Simplified Scenario Testing: Easily evaluate various assumptions and analyze results side-by-side.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Download: Obtain the pre-configured Excel file containing Senti Biosciences, Inc.'s (SNTI) financial data.
  • Customize: Modify projections such as revenue growth, EBITDA %, and WACC to fit your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you make changes.
  • Test Scenarios: Develop various forecasts and instantly compare the results.
  • Make Decisions: Leverage the valuation insights to inform your investment choices.

Why Choose This Calculator for Senti Biosciences, Inc. (SNTI)?

  • Designed for Experts: A sophisticated tool utilized by researchers, investors, and biotech analysts.
  • Comprehensive Data: Senti Biosciences’ historical and projected financials preloaded for precision.
  • Flexible Scenario Analysis: Easily simulate various projections and assumptions.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance to facilitate your calculations.

Who Should Use This Product?

  • Investors: Accurately assess Senti Biosciences, Inc.’s (SNTI) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to SNTI.
  • Consultants: Easily customize the template for valuation reports tailored to Senti Biosciences, Inc. (SNTI) clients.
  • Entrepreneurs: Acquire insights into financial modeling practices used by leading biotech firms.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies in the biotech sector.

What the Template Contains

  • Preloaded SNTI Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.